Press Release
-
- (2023-04-17) AimedBio's poster presentation at AACR 2023
- 2023.07.18
-
- (2023-03-15) Aimed-GeneQuantum reveals 'FGFR3-ADC' preclinical data at World ADC
- 2023.07.18
-
- (2022-11-11) AimedBio scores second 'KDDF' grant with its immune therapeutics targeting tumor-associated macrophages
- 2023.02.28
-
- (2022-09-13) AimedBio joins ‘Lee Kun-hee’s support for children with cancers and rare diseases’ with its precision medicine platform AVATASCAN®
- 2023.02.28
-
- (2022-07-29) AimedBio and GCcell collaborates on the next generation CAR-NK cell therapy development
- 2023.02.28
-
- (2022-07-27) Parkinson's treatment strategies and cell therapy research results shared at AimedBio's 2nd Parkinson's Disease salon
- 2023.02.28
-
- (2022-05-17) AimedBio develops antibodies with novel targets based on ‘patient big data’
- 2023.02.28
-
- (2022-04-19) GeneQuantum and AimedBio collaborate on a First-In-Class Antibody-Drug-Conjugate
- 2023.02.28
-
- (2021-11-05) AimedBio’s possible first-in-class brain tumor therapeutics selected by the KDDF
- 2023.02.28
